Loading…
HCA Healthcare
HCA · NYSE · Health Care Facilities
HCA · NYSE · Health Care Facilities
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Fund holdings · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Viking Global no longer reported HCA for Q2 2026SourceFund holdings · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Bridgewater Associates disclosed an increased position in HCA for Q2 2026SourceCongress trade · Transaction Jun 17, 2026 · Disclosed Jul 26, 2026
Disclosed purchase of HCA — reported range $1,001 - $15,000SourceCongress trade · Transaction Jun 17, 2026 · Disclosed Jul 26, 2026
Disclosed purchase of HCA — reported range $1,001 - $15,000SourceCongress trade · Transaction Mar 27, 2026 · Disclosed Jul 21, 2026
Disclosed purchase of HCA — reported range $1,001 - $15,000SourceInsider trade · Traded Feb 18, 2026 · Filed Feb 19, 2026
Officer sold ~$904K of HCA shares in the open marketSourceInsider trade · Traded Feb 11, 2026 · Filed Feb 12, 2026
Officer sold ~$2.11M of HCA shares in the open marketSourceInsider trade · Traded Feb 11, 2026 · Filed Feb 12, 2026
Officer sold ~$2.02M of HCA shares in the open marketSourceInsider trade · Traded Feb 11, 2026 · Filed Feb 12, 2026
Officer sold ~$2.02M of HCA shares in the open marketSourceInsider trade · Traded Nov 5, 2025 · Filed Nov 5, 2025
Officer sold ~$1.84M of HCA shares in the open marketSourceCongress trade · Transaction Sep 11, 2025 · Disclosed Oct 22, 2025
Disclosed sale of HCA — reported range $1,001 - $15,000SourceCongress trade · Transaction Dec 27, 2024 · Disclosed Sep 12, 2025
Disclosed sale of HCA — reported range $1,001 - $15,000SourceCongress trade · Transaction Oct 29, 2024 · Disclosed Sep 12, 2025
Disclosed purchase of HCA — reported range $1,001 - $15,000SourceCongress trade · Transaction Aug 19, 2025 · Disclosed Sep 12, 2025
Disclosed purchase of HCA — reported range $1,001 - $15,000SourceCongress trade · Transaction May 15, 2025 · Disclosed Jun 27, 2025
Disclosed purchase of HCA — reported range $1,001 - $15,000SourceCongress trade · Transaction May 15, 2025 · Disclosed Jun 27, 2025
Disclosed purchase of HCA — reported range $1,001 - $15,000SourceCongress trade · Transaction Apr 7, 2025 · Disclosed May 14, 2025
Disclosed sale of HCA — reported range $1,001 - $15,000SourceCongress trade · Transaction Feb 25, 2025 · Disclosed Mar 27, 2025
Disclosed sale of HCA — reported range $1,001 - $15,000Source5%+ stake, activist · Stake as of Feb 6, 2026 · Filed Feb 10, 2026
Thomas F. Frist, Jr. disclosed a 31.6% stake in HCA and may seek to influence the companySourceInsider trade · Traded Feb 3, 2026 · Filed Feb 5, 2026
CEO sold ~$7.4M of HCA shares in the open marketSourceInsider trade · Traded Feb 3, 2026 · Filed Feb 5, 2026
CEO sold ~$3.7M of HCA shares in the open marketSourceInsider trade · Traded Feb 3, 2026 · Filed Feb 5, 2026
CEO sold ~$3.09M of HCA shares in the open marketSourceInsider trade · Traded Feb 3, 2026 · Filed Feb 5, 2026
CEO sold ~$2.57M of HCA shares in the open marketSourceInsider trade · Traded Feb 3, 2026 · Filed Feb 5, 2026
CEO sold ~$2.51M of HCA shares in the open marketSourceInsider trade · Traded Feb 3, 2026 · Filed Feb 5, 2026
CEO sold ~$2.14M of HCA shares in the open marketSourceInsider trade · Traded Feb 3, 2026 · Filed Feb 5, 2026
Officer sold ~$747K of HCA shares in the open marketSourceInsider trade · Traded Feb 3, 2026 · Filed Feb 5, 2026
CEO sold ~$60K of HCA shares in the open marketSource